Inflation Reduction Act

Pfizer CEO points to IRA as a factor that made Seagen an attractive target
Pfizer CEO points to IRA as a factor that made Seagen an attractive target
Endpoints
Pfizer
Seagen
M&A
Inflation Reduction Act
Flag link:
Medicare announces plan to recoup billions from drug companies
Medicare announces plan to recoup billions from drug companies
NPR
Medicare
drug pricing
Inflation Reduction Act
Flag link:
Inside pharma’s push to amend new drug-pricing law
Inside pharma’s push to amend new drug-pricing law
Medical Marketing and Media
drug pricing
Inflation Reduction Act
Flag link:
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Novartis CEO, as incoming PhRMA chair, outlines 3 priorities for pharma after IRA setback
Fierce Pharma
Novartis
Vas Narasimhan
PhRMA
Inflation Reduction Act
PBMs
small molecule drugs
Flag link:
Legislative Hurdles Anticipated for Biopharma in 2023
Legislative Hurdles Anticipated for Biopharma in 2023
BioSpace
legislation
M&A
FDA
Inflation Reduction Act
Flag link:
JPM2023: Breakthroughs await, but so do roadblocks
JPM2023: Breakthroughs await, but so do roadblocks
Pharmaphorum
JPMHC 2023
Inflation Reduction Act
cell therapy
gene therapy
clinical trials
CNS disorders
Flag link:
5 questions facing emerging biotech in 2023
5 questions facing emerging biotech in 2023
BioPharma Dive
biotech
IPOs
platform companies
funding
restructuring
Inflation Reduction Act
Flag link:
Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper
Aligning drug prices with ICER estimates could save tens of billions of dollars — JAMA paper
Endpoints
ICER
Inflation Reduction Act
drug pricing
Flag link:
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Bristol Myers Squibb Threatens New Rules Will Hinder Drug Production
Motley Fool
Bristol Myers Squibb
drug development
Inflation Reduction Act
Flag link:
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
Sanofi, Alnylam Q3 Reports Hint at Early Pipeline Impacts from IRA
BioSpace
Sanofi
Alnylam
earnings
Inflation Reduction Act
legislation
drug pricing
Flag link:
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Alnylam scraps trial in rare eye disorder, blaming drug price reforms
Pharmaphorum
Alnylam
RNAi
vutrisiran
Stargardt disease
Inflation Reduction Act
drug pricing
Flag link:
US govt addressing Medicare payments for biosimilars
US govt addressing Medicare payments for biosimilars
Pharma Letter
HHS
Medicare
biosimilars
Medicare Part B
Inflation Reduction Act
CMS
Flag link:
New drug price law could help Part D enrollees who can't fill cancer treatments due to costs, White House says
New drug price law could help Part D enrollees who can't fill cancer treatments due to costs, White House says
Endpoints
Medicare Part D
drug pricing
Inflation Reduction Act
Flag link:
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Inflation Reduction Act
Joe Biden
Novo Nordisk
Gilead Sciences
Bristol Myers Squibb
AstraZeneca
drug pricing
Flag link:
Amgen CEO Robert Bradway warns Biden's Inflation Reduction Act could blunt future biotech success stories
Amgen CEO Robert Bradway warns Biden's Inflation Reduction Act could blunt future biotech success stories
Fierce Pharma
Amgen
Bob Bradway
Pharma CEOs
Inflation Reduction Act
Flag link:
The Inflation Reduction Act’s Potential Impact on Research, Launch Strategy
The Inflation Reduction Act’s Potential Impact on Research, Launch Strategy
BioSpace
Inflation Reduction Act
Medicare
R&D
drug launches
Flag link:
What “Negotiating” With Medicare Means For Drug Makers: A Mixture Of Price Controls And Actual Negotiations
What “Negotiating” With Medicare Means For Drug Makers: A Mixture Of Price Controls And Actual Negotiations
Forbes
drug pricing
Medicare
Inflation Reduction Act
Flag link:
US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says
US drug pricing reform in Inflation Reduction Act could harsh pharma's credit, Moody's says
Fierce Pharma
legislation
Inflation Reduction Act
drug pricing
Big Pharma
Joe Biden
credit
Flag link:
Drug Pricing Debates Heat Up Just in Time for Election Season
Drug Pricing Debates Heat Up Just in Time for Election Season
BioSpace
drug pricing
Inflation Reduction Act
legislation
elections
Flag link: